D-0857-2016 Class II Terminated
FDA drug recall D-0857-2016 was initiated by Pfizer Inc. on Apr 28, 2016 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found. The recall status is terminated (terminated Jul 26, 2017). Affected quantity: 68, 214 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 1, 2016
- Initiation Date
- Apr 28, 2016
- Termination Date
- Jul 26, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 68, 214 bottles
Product description
Zoloft (sertraline HCl) tablets, 100 mg*, 30 count bottles, Rx only, Distributed by Roerig, Division of Pfizer, Inc., NY NY 10017, NDC 0049-4910-30.
Reason for recall
Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: M25569, Exp 08/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0857-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.